Home

Occasionally diet The actual triple therapy after pci 6 months Have a picnic residue desirable

Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI  for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and  after... 🧐 and finally (N)OAC alone! #
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With  Oral Anticoagulation Undergoing Percutaneous Coronary Intervention |  Circulation
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation

Update on antithrombotic therapy after percutaneous coronary  revascularisation.,The Lancet - X-MOL
Update on antithrombotic therapy after percutaneous coronary revascularisation.,The Lancet - X-MOL

Triple therapy: A review of antithrombotic treatment for patients with  atrial fibrillation undergoing percutaneous coronary intervention -  ScienceDirect
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect

Antithrombotic therapy after pci in atrial fibrillation 2016
Antithrombotic therapy after pci in atrial fibrillation 2016

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline  Comparison - ScienceDirect
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect

Antithrombotic Treatment After Coronary Intervention: Agreement and  Controversy | ECR Journal
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy | ECR Journal

Cardiovascular Medicine - Novel directions for the management of dual  antiplatelet therapy in patients with coronary artery disease
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease

REC: Interventional Cardiology - Special article
REC: Interventional Cardiology - Special article

6-month versus 12-month or longer dual antiplatelet therapy after  percutaneous coronary intervention in patients with acute coronary syndrome  (SMART-DATE): a randomised, open-label, non-inferiority trial.,The Lancet -  X-MOL
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.,The Lancet - X-MOL

Cardiovascular Medicine - Novel directions for the management of dual  antiplatelet therapy in patients with coronary artery disease
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease

Antithrombotic therapy after an ACS in atrial fibrillation patients... |  Download Scientific Diagram
Antithrombotic therapy after an ACS in atrial fibrillation patients... | Download Scientific Diagram

Duration of triple therapy in patients requiring oral
Duration of triple therapy in patients requiring oral

Figure 2 | Antithrombotic therapy after percutaneous coronary intervention  from the Japanese perspective | SpringerLink
Figure 2 | Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective | SpringerLink

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet  Therapy in Patients With Coronary Artery Disease: A Repor
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Repor

Management of Antithrombotic Therapy in Atrial Fibrillation Patients  Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect

Antithrombotic therapy after an ACS in atrial fibrillation patients... |  Download Scientific Diagram
Antithrombotic therapy after an ACS in atrial fibrillation patients... | Download Scientific Diagram

British Cardiovascular Society
British Cardiovascular Society

Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous  coronary intervention with stenting - Journal of Cardiology
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the

Dual antiplatelet therapy for secondary prevention of coronary artery  disease | Open Heart
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart

JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome:  What is New and Why? Insight From the 2020 European Society of Cardiology  Guidelines | HTML
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML

Do the New DAPT Guidelines Result in Any Real Changes in Practice? -  Cardiac Interventions Today
Do the New DAPT Guidelines Result in Any Real Changes in Practice? - Cardiac Interventions Today

Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary  Results of the AUGUSTUS Trial - American College of Cardiology
Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial - American College of Cardiology

Drug-eluting stents in patients on long-term oral anticoagulation therapy:  a mission impossible?
Drug-eluting stents in patients on long-term oral anticoagulation therapy: a mission impossible?

Atrial fibrillation with percutaneous coronary intervention: Navigating the  minefield of antithrombotic therapies - Atherosclerosis
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis